Carisoprodol
Product Images NDC 10544-033

2 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 10544-033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is A Picture Of The Label Carisoprodol Tablets, Usp, 350 mg, 100 Count. (Carisoprodol 2)

This Is A Picture Of The Label Carisoprodol Tablets, Usp, 350 mg, 100 Count. (Carisoprodol 2)
Carisoprodol Tablets, USP 350mg label showing product name, strength, dosage form, and quantity of 30 tablets. The label indicates prescription use (Rx Only), storage instructions, and manufacturer information for Blenheim Pharmacal, Inc. The NDC is 10544-033-30 with lot number and expiration date fields visible.*
FDA Label Image

This In An Image Of The Structural Formula Of Carisoprodol. (Image 01)

This In An Image Of The Structural Formula Of Carisoprodol. (Image 01)
Chemical structure of carisoprodol, showing its molecular formula with functional groups and carbon backbone arrangement, as supplied by Blenheim Pharmacal, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.